Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection. TRIAL DESIGN: This is a prospective, single-center, phase 2, randomized, controlled trial that is blinded to participants and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Trials
Main Authors: Eckhardt, Christina M., Cummings, Matthew J., Rajagopalan, Kartik N., Borden, Sarah, Bitan, Zachary C., Wolf, Allison, Kantor, Alex, Briese, Thomas, Meyer, Benjamin J., Jacobson, Samuel D., Scotto, Dawn, Mishra, Nischay, Philip, Neena M., Stotler, Brie A., Schwartz, Joseph, Shaz, Beth, Spitalnik, Steven L., Eisenberg, Andrew, Hod, Eldad A., Justman, Jessica, Cheung, Ken, Lipkin, W. Ian, O’Donnell, Max R.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Letter
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276974/
https://ncbi.nlm.nih.gov/pubmed/32513308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04422-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares